These findings suggest that COVID-19 vaccines, particularly mRNA vaccines, may enhance TGF-β1-mediated processes such as mitosis, angiogenesis, cell migration, and extracellular matrix remodeling in ovarian tissue, particularly within follicles composed of diverse cell types and structures. This evidence concerns the gene TGFB1 and COVID-19.